DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 3470--------------------------------------------------
       Tecfidera vs Gilenya, Rituxan vs Tysabri compared
       By: agate Date: November 21, 2021, 1:43 am
       ---------------------------------------------------------
       From JAMA (November 16, 2021)--"Comparison of dimethyl fumarate
       vs fingolimod and rituximab vs natalizumab for treatment of
       multiple sclerosis":
  HTML https://bit.ly/3FBGAJU
       [quote]Findings:  [font=guardian textsans web]This comparative
       effectiveness study integrated electronic health records with
       research registry data and found no significant differences in
       relapse outcomes between dimethyl fumarate and fingolimod after
       correcting for confounding biases. Rituximab was associated with
       a lower relapse rate when compared with natalizumab after bias
       correction.[/font][/quote]
       *****************************************************